These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26580093)

  • 1. Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants.
    Gandhi DJ; Dhaded SM; Ravi MD; Dubey AP; Kundu R; Lalwani SK; Chhatwal J; Mathew LG; Gupta M; Sharma SD; Bavdekar SB; Jayanth MV; Ravinuthala S; Sil A; Dhingra MS
    Hum Vaccin Immunother; 2016 Apr; 12(4):946-54. PubMed ID: 26580093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.
    Sharma HJ; Yadav S; Lalwani SK; Kapre SV; Jadhav SS; Chakravarty A; Parekh SS; Palkar S; Bhardwaj SH; Namjoshi GS; Verma V
    Hum Vaccin; 2011 Apr; 7(4):451-7. PubMed ID: 21403463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
    Sil A; Ravi MD; Patnaik BN; Dhingra MS; Dupuy M; Gandhi DJ; Dhaded SM; Dubey AP; Kundu R; Lalwani SK; Chhatwal J; Mathew LG; Gupta M; Sharma SD; Bavdekar SB; Rout SP; Jayanth MV; D'Cor NA; Mangarule SA; Ravinuthala S; Reddy E J
    Vaccine; 2017 May; 35(22):2999-3006. PubMed ID: 28449972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
    Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM
    Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP-HepB-Hib vaccine in indian infants.
    Eregowda A; Lalwani S; Chatterjee S; Vakil H; Ahmed K; Costantini M; Lattanzi M
    Hum Vaccin Immunother; 2013 Sep; 9(9):1903-9. PubMed ID: 23783081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
    Aloysia D'Cor N; Siddaiah P; Mohapatra S; Dhaded SM; I V P; Kar S; V N T; Muley P; Chhatwal J; Patnaik BN; Vidor E; Moureau A; Patel DM; Midde VJ; Jagga SR; Peesapati S; Noriega F
    PLoS One; 2023; 18(8):e0284898. PubMed ID: 37582114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
    Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
    Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine.
    Sharma H; Yadav S; Lalwani S; Kapre S; Jadhav S; Parekh S; Palkar S; Ravetkar S; Bahl S; Kumar R; Shewale S
    Vaccine; 2013 Jan; 31(3):444-7. PubMed ID: 23196204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem (®) demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine.
    Aspinall S; Traynor D; Bedford P; Hartmann K
    Hum Vaccin Immunother; 2012 Aug; 8(8):1109-18. PubMed ID: 22854660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador.
    Suárez E; Asturias EJ; Hilbert AK; Herzog C; Aeberhard U; Spyr C
    Rev Panam Salud Publica; 2010 Feb; 27(2):117-24. PubMed ID: 20339615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers.
    Lee AW; Jordanov E; Boisnard F; Marshall GS
    Expert Rev Vaccines; 2017 Feb; 16(2):85-92. PubMed ID: 27996332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
    Capeding MR; Alberto E; Versteilen A; Rauscher M; Bagchi P; Palacios PI
    Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study.
    Susarla SK; Gupta M; Mantan M; Dhongade R; Bhave S; Das RK; Ray RK; Ramesh Babu T; Ravi MD; Krishnamurthy B; James S; Sandhya G; Satish M; Sahoo DP
    Vaccine; 2019 Aug; 37(36):5452-5459. PubMed ID: 31331773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
    Szenborn L; Czajka H; Brzostek J; Konior R; Caubet M; Ulianov L; Leyssen M
    Pediatr Infect Dis J; 2013 Jul; 32(7):777-85. PubMed ID: 23838777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD005530. PubMed ID: 22513932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine.
    Gentile A; Umido V; Czerniuk P; Nacul J; Seigelchifer M; Hilbert AK; Yela U; Herzog C; Aeberhard U; Spyr C
    Int J Infect Dis; 2011 Jan; 15(1):e24-9. PubMed ID: 21093342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of age.
    Thollot F; Scheifele D; Pankow-Culot H; Cheuvart B; Leyssen M; Ulianov L; Miller JM
    Pediatr Infect Dis J; 2014 Dec; 33(12):1246-54. PubMed ID: 25037033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
    Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
    Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.